Loading articles...

Canadian drug makers hit with $1.1B suit for pushing opioids despite risks

Last Updated May 19, 2019 at 8:34 am PDT

Prescription pills containing oxycodone and acetaminophen are shown in Toronto, Dec. 23, 2017. With the recognition that physician prescribing plays a significant role in Canada's opioid crisis, a team of researchers has developed a program called STOP Narcotics to dramatically reduce the amount of the painkillers patients are given following some common operations. THE CANADIAN PRESS/Graeme Roy

TORONTO — Canadian drug makers are facing a $1.1-billion lawsuit for their role in the opioid crisis.

A proposed class action filed May 15 accuses almost two dozen companies of enriching themselves at the expense of vulnerable patients.

The unproven suit alleges the companies illegally and deceptively promoted highly addictive opioids despite knowing the dangers

The potent painkillers have killed thousands of Canadians in recent years.

The statement of claim filed in Ontario Superior Court names some of the biggest pharmaceutical firms in the country.

No statements of defence have been filed and the claims have not been tested in any court.

The Canadian Press